Skip to main content
. 2020 Jun 2;26(6):528–536. doi: 10.1177/1753425920928449

Figure 3.

Figure 3.

Inhibition of miR-128-3p could alleviate mouse liver I/R injury. (a) and (b) Relative miR-128-3p and Rnd3 mRNA levels in a mouse liver I/R model served with miR-128-3p antagomir. (c) and (d) Serum ALT and AST levels after being treated with miR-128-3p antagomir. (e) and (f) Serum TNF-α and IL-6 levels after being treated with miR-128-3p antagomir. (g)–(i) Relative Rnd3 and NF-κB p65 protein expression after being treated with miR-128-3p antagomir. (j) and (k) Histological changes of the liver in the sham, I/R, I/R + miR-128-3p NC and I/R + 3miR-128-3p antagomir groups. Original magnification ×200. n = 5. *P < 0.05; **P < 0.01; ***P < 0.001; ns P > 0.05.